Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Menadione added to perioperative FLOT for stomach cancer
RBR-76j763kPhase 2Recruiting
- Sponsor
- Hospital Ophir Loyola
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of menadione in gastric cancer (GC), sponsored by Hospital Ophir Loyola. Started Feb 2022; status: recruiting.
02
Drugs
menadione
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on RBR-76j763k.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-76j763k.